Steven G. Smith
AstraZeneca (Netherlands)(NL)AstraZeneca (Singapore)(SG)
Publications by Year
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Sinusitis and nasal conditions
Most-Cited Works
- → Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study(2018)540 cited
- → Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial(2021)539 cited
- → Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia(2015)449 cited
- → The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia(2023)434 cited
- → Selective RET kinase inhibition for patients with RET-altered cancers(2018)426 cited
- → Cyclosporine in severe childhood atopic dermatitis: A multicenter study(1996)198 cited